Habib Dable
Chairman bei AEROVATE THERAPEUTICS, INC.
Vermögen: 616 590 $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Habib Dable
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
127
| Public Company | Pharmaceuticals: Major | 127 |
| Subsidiary | Biotechnology | 32 | |
| Public Company | Biotechnology | 25 | |
| Unknown | 19 | ||
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
16
| Public Company | Biotechnology | 16 |
| Public Company | Biotechnology | 15 | |
| Subsidiary | Pharmaceuticals: Major | 13 | |
| Extinct | Pharmaceuticals: Major | 11 | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
6
| Non-Profit Organization | Miscellaneous Commercial Services | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Habib Dable
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President Private Equity Investor Compliance Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Washington University in St. Louis | College/University | Undergraduate Degree Masters Business Admin | |
| ARQULE, INC. | Pharmaceuticals: Major | President Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Harrisvaccines LLC
 Harrisvaccines LLC BiotechnologyHealth Technology Harrisvaccines LLC develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle. Its pipeline products comprise vaccines for viral diseases. The company was founded by Hank Harris in 2005 and is headquartered in Ames, IA. | Biotechnology | President Director/Board Member | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| BMW AG | Motor Vehicles | Chairman Director/Board Member | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor Private Equity Investor Private Equity Investor Private Equity Investor | |
Bayer CropScience AG
 Bayer CropScience AG Chemicals: AgriculturalProcess Industries Bayer CropScience AG manufactures and distributes pesticides, and vegetable seeds. Its products include crops such as cotton, fruits and vegetables, oil seeds and wheat, brands includes fungicides, herbicides and seeds growth. The company was founded in 1979 and is headquartered In Monheim am Rhein, Germany. | Chemicals: Agricultural | Chairman Director/Board Member Director/Board Member | |
| McGill University | College/University | Doctorate Degree Doctorate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Wesleyan University | College/University | Undergraduate Degree Undergraduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
Currenta Geschäftsführungs GmbH
 Currenta Geschäftsführungs GmbH Miscellaneous Commercial ServicesCommercial Services Currenta Geschäftsführungs GmbH is a company based in Leverkusen, Germany. and has subsidiaries in Germany. The German company specializes in supply, waste management, safety, and the management of the chempark. The company provides customized solutions to their customers, ranging from material and energy supply to the development of disposal and safety concepts, as well as support in approval procedures. Currenta offers their services to the chemical and chemical-related industries both inside and outside chempark, creating high and sustainable value. | Miscellaneous Commercial Services | Chairman Chairman | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| AVROBIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| FUSN PHAR | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VOR BIOPHARMA INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree Undergraduate Degree | |
| VERVE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Leaps by Bayer
 Leaps by Bayer Investment ManagersFinance Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany. | Investment Managers | Private Equity Investor Human Resources Officer | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Founder Chairman Founder | |
| PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Founder | |
| THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member | |
IDRx, Inc.
 IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder | |
Pheon Therapeutics Ltd.
 Pheon Therapeutics Ltd. BiotechnologyHealth Technology Pheon Therapeutics Ltd. is an antibody drug conjugate (ADC) specialist that develops a pipeline of monotherapies for novel targets and/or with novel payloads. The company is based in Harpdenden, UK. The British company's lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types. ADCs offer the potential to treat solid tumors and liquid cancers that have not responded to other treatments. The company was founded in 2015 by Paul Jackson. Cyrus D. Mozayeni has been the CEO of the company since 2023. | Biotechnology | Chairman Director/Board Member |
Statistik
International
| Vereinigte Staaten | 38 |
| Deutschland | 8 |
| Kanada | 3 |
| Vereinigtes Königreich | 3 |
| Frankreich | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 13 |
| Finance | 6 |
| Commercial Services | 4 |
| Consumer Durables | 2 |
Operativ
| Director/Board Member | 413 |
| Corporate Officer/Principal | 197 |
| Independent Dir/Board Member | 137 |
| Chairman | 89 |
| Chief Executive Officer | 73 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Joshua Resnick | 36 |
| George Golumbeski | 36 |
| Jürgen Eckhardt | 34 |
| Karl-Ludwig Kley | 32 |
| Dieter Weinand | 32 |
| Francois Nader | 28 |
| Maha Katabi | 28 |
| Mark Iwicki | 26 |
| Alexis Borisy | 25 |
| Mike Gutch | 24 |
| Michael Gladstone | 23 |
| Dave Grayzel | 23 |
| Heidi Henson | 20 |
| Donald Santel | 20 |
| Sona Saira Ramasastry | 19 |
- Börse
- Insiders
- Habib Dable
- Unternehmensverbindungen
